ASH Highlights and Commentary: Additional Topics of Interest

Abstract

Dr. Tinsley provides insight for APs on the use of pevonedistat, a new small-molecule inhibitor. Dr. Kurtin considers the use of the CRISPR technique to detect COVID-19 in patients with hematologic malignancies and data from a retrospective observational cohort study describing the disease burden of primary cold agglutinin disease.